Advertisement | | Leukemia: Collection on Acute Myeloid Leukemia AML is an area of focus for Leukemia and this collection brings together a number of recent key articles published in the journal. Access this collection free online for six months Funded by a grant from Astex Pharmaceuticals, Inc. (a member of the Otsuka group) | | | | | |
TABLE OF CONTENTS
| | | | Volume 52, Issue 7 (July 2017) | | In this issue Review Commentaries Original Articles Letter To The Editor Corrigenda
Also new AOP | | | | Review | Top | | Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a reviewG Damaj, J Cornillon, K Bouabdallah, R Gressin, S Vigouroux, T Gastinne, F Ranchon, H Ghésquières, G Salles, I Yakoub-Agha and E Gyan for Lymphoma Study Association and the French Society of Bone Marrow Transplantation and Cellular Therapy Bone Marrow Transplant 2017 52: 941-949; advance online publication, January 23, 2017; 10.1038/bmt.2016.340 Abstract | Full Text | | Commentaries | Top | | Allogeneic transplantation in primary refractory AMLP Ferguson and C Craddock Bone Marrow Transplant 2017 52: 950-951; advance online publication, April 24, 2017; 10.1038/bmt.2017.61 Full Text | | Minimal residual disease assessment by next-generation sequencing. Better tools to gaze into the crystal ball?A Balduzzi Bone Marrow Transplant 2017 52: 952-954; advance online publication, June 5, 2017; 10.1038/bmt.2017.104 Full Text | | Original Articles | Top | | ACUTE LEUKEMIA | Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)E Todisco, F Ciceri, C Boschini, F Giglio, A Bacigalupo, F Patriarca, I Donnini, E P Alessandrino, W Arcese, A P Iori, P Marenco, I Cavattoni, P Chiusolo, E Terruzzi, L Castagna, A Santoro, A Bosi, E Oldani, B Bruno, F Bonifazi and A Rambaldi Bone Marrow Transplant 2017 52: 955-961; advance online publication, January 9, 2017; 10.1038/bmt.2016.325 Abstract | Full Text | | Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALLM Kotrova, V H J van der Velden, J J M van Dongen, R Formankova, P Sedlacek, M Brüggemann, J Zuna, J Stary, J Trka and E Fronkova Bone Marrow Transplant 2017 52: 962-968; advance online publication, February 27, 2017; 10.1038/bmt.2017.16 Abstract | Full Text | | LYMPHOMA | Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphomaS Yamasaki, R Suzuki, K Hatano, K Fukushima, H Iida, S Morishima, Y Suehiro, T Fukuda, N Uchida, H Uchiyama, H Ikeda, A Yokota, K Tsukasaki, H Yamaguchi, J Kuroda, H Nakamae, Y Adachi, K-i Matsuoka, Y Nakamura, Y Atsuta and J Suzumiya Bone Marrow Transplant 2017 52: 969-976; advance online publication, April 3, 2017; 10.1038/bmt.2017.52 Abstract | Full Text | | APLASTIC ANEMIA | Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation OPENE Mohanan, J C Panetta, K M Lakshmi, E S Edison, A Korula, N A Fouzia, A Abraham, A Viswabandya, V Mathews, B George, A Srivastava and P Balasubramanian Bone Marrow Transplant 2017 52: 977-983; advance online publication, May 8, 2017; 10.1038/bmt.2017.79 Abstract | Full Text | | TRANSPLANT TOXICITIES | Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhoodD Bresters, D C M Wanders, M Louwerens, L M Ball, M Fiocco and R van Doorn Bone Marrow Transplant 2017 52: 984-988; advance online publication, March 20, 2017; 10.1038/bmt.2017.15 Abstract | Full Text | | Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantationJ S Song, W B London, E B Hawryluk, D Guo, M Sridharan, D E Fisher, L E Lehmann, C N Duncan and J T Huang Bone Marrow Transplant 2017 52: 989-997; advance online publication, April 3, 2017; 10.1038/bmt.2017.57 Abstract | Full Text | | Association of hematopoietic cell transplantation-specific comorbidity index with resource utilization after allogeneic transplantationL Decook, Y-H Chang, J Slack, D Gastineau, J Leis, P Noel, J Palmer, L Sproat, M Sorror and N Khera Bone Marrow Transplant 2017 52: 998-1002; advance online publication, April 24, 2017; 10.1038/bmt.2017.70 Abstract | Full Text | | GRAFT-VERSUS-HOST DISEASE | Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD preventionF Khimani, J Kim, L Chen, E Dean, V Rizk, B Betts, T Nishihori, F Locke, A Mishra, L Perez, E Ayala, M Kharfan-Dabaja, M Nieder, H Fernandez, C Anasetti and J Pidala Bone Marrow Transplant 2017 52: 1003-1009; advance online publication, April 3, 2017; 10.1038/bmt.2017.63 Abstract | Full Text | | B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortalityR M Saliba, S Sarantopoulos, C L Kitko, A Pawarode, S C Goldstein, J Magenau, A M Alousi, T Churay, H Justman, S Paczesny, P Reddy and D R Couriel Bone Marrow Transplant 2017 52: 1010-1015; advance online publication, May 8, 2017; 10.1038/bmt.2017.73 Abstract | Full Text | | INFECTIONS | A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipientsY Natori, A Humar, J Lipton, D D Kim, P Ashton, K Hoschler and D Kumar Bone Marrow Transplant 2017 52: 1016-1021; advance online publication, March 6, 2017; 10.1038/bmt.2017.24 Abstract | Full Text | | QOL AND PATIENTS' CARE | Fertility preservation practices in pediatric and adolescent cancer patients undergoing HSCT in Europe: a population-based surveyT Diesch, A Rovo, N von der Weid, M Faraci, M Pillon, A Dalissier, J-H Dalle and P Bader Bone Marrow Transplant 2017 52: 1022-1028; advance online publication, January 23, 2017; 10.1038/bmt.2016.363 Abstract | Full Text | | State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29–30 September 2015J-H Dalle, G Lucchini, A Balduzzi, M Ifversen, K Jahnukainen, K T Macklon, A Ahler, A Jarisch, M Ansari, E Beohou, D Bresters, S Corbacioglu, A Dalissier, C Diaz de Heredia Rubio, T Diesch, B Gibson, T Klingebiel, A Lankester, A Lawitschka, R Moffat, C Peters, C Poirot, N Saenger, P Sedlacek, E Trigoso, K Vettenranta, J Wachowiak, A Willasch, M von Wolff, I Yaniv, A Yesilipek and P Bader on behalf of the EBMT Paediatric Diseases Working Party Bone Marrow Transplant 2017 52: 1029-1035; advance online publication, March 13, 2017; 10.1038/bmt.2017.21 Abstract | Full Text | | Letter To The Editor | Top | | Unconditioned unrelated donor bone marrow transplantation for IL7Rα- and Artemis-deficient SCIDC C Dvorak, K Patel, J M Puck, J Wahlstrom, M J Dorsey, R Adams, J Facchino and M J Cowan Bone Marrow Transplant 2017 52: 1036-1038; advance online publication, April 24, 2017; 10.1038/bmt.2017.74 Full Text | | When selecting a cord blood unit from a firstborn donor verify that the patient shares an Ag with the unit that is foreign to the mother of the donorJ J van Rood, A Brand, A Scaradavou, F H Claas, M Oudshoorn and C E Stevens Bone Marrow Transplant 2017 52: 1039-1040; advance online publication, April 24, 2017; 10.1038/bmt.2017.75 Full Text | | Dental status does not predict infection during stem cell transplantation: a single-center surveyA Guenther, E Losch, M Schiessl, A Schrauder, A Humpe, R Repp, T Nitsche, J Wiltfang and M Gramatzki Bone Marrow Transplant 2017 52: 1041-1043; advance online publication, May 8, 2017; 10.1038/bmt.2017.76 Full Text | | Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from SingaporeM B Abid, D Christopher, M A Abid, M L Poon, L K Tan, L P Koh and W J Chng Bone Marrow Transplant 2017 52: 1044-1046; advance online publication, May 8, 2017; 10.1038/bmt.2017.77 Full Text | | Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantationF-X Gros, T Cazaubiel, E Forcade, N Lechevalier, T Leguay, V Servant, R Tabrizi, L Clement, P-Y Dumas, A Bidet, A Pigneux, S Vigouroux and N Milpied Bone Marrow Transplant 2017 52: 1047-1048; advance online publication, June 5, 2017; 10.1038/bmt.2017.78 Full Text | | Addition of plerixafor to G-CSF is useful to achieve efficient collection even in very poor mobilizers: hope for patients with diminished hematopoietic functionM Mohty, P Drillat, J-M Grouin, F Bijou, N Milpied and C Chabannon Bone Marrow Transplant 2017 52: 1049-1050; advance online publication, May 22, 2017; 10.1038/bmt.2017.80 Full Text | | A severe umbilical cord stem cell infusion reaction due to dextran in an atopic pediatric patientL Cooling, A Sankar, R Mody, G Yanik, C Bonifant and S W Choi Bone Marrow Transplant 2017 52: 1051-1053; advance online publication, March 6, 2017; 10.1038/bmt.2017.33 Full Text | | Nivolumab before and after allogeneic hematopoietic cell transplantationF Covut, R Pinto, B W Cooper, B Tomlinson, L Metheny, E Malek, H M Lazarus, M de Lima and P F Caimi Bone Marrow Transplant 2017 52: 1054-1056; advance online publication, March 27, 2017; 10.1038/bmt.2017.44 Full Text | | Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignanciesA Liou, J T Wahlstrom, C C Dvorak and B N Horn Bone Marrow Transplant 2017 52: 1057-1059; advance online publication, April 10, 2017; 10.1038/bmt.2017.45 Full Text | | Skin allograft for severe chronic GvHDR Crocchiolo, V Dubois, F-E Nicolini, M Sobh, S Ducastelle-Lepretre, H Labussiere, L Lebras, C Auxenfans, A Mojallal, O Damour, F Braye and M Michallet Bone Marrow Transplant 2017 52: 1060-1062; advance online publication, March 27, 2017; 10.1038/bmt.2017.53 Full Text | | Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrierA Garnier, T Guillaume, P Peterlin, M C Béné, Y Le Bris, V Dubruille, B Mahé, T Gastinne, C Touzeau, N Blin, S Le Gouill, P Moreau and P Chevallier Bone Marrow Transplant 2017 52: 1063-1064; advance online publication, April 3, 2017; 10.1038/bmt.2017.60 Full Text | | Successful chimeric Ag receptor modified T cell therapy for isolated testicular relapse after hematopoietic cell transplantation in an acute lymphoblastic leukemia patientJ Yu, Y Hu, C Pu, Z Liang, Q Cui, H Zhang, Y Luo, J Shi, A Jin, L Xiao, Z Wu and H Huang Bone Marrow Transplant 2017 52: 1065-1067; advance online publication, April 24, 2017; 10.1038/bmt.2017.64 Full Text | | Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantationS Yamamoto, R Matsuno, Y Sugishita, R Kaneko, N Okamoto, M Koganesawa, S Fujita, K Akiyama, D Toyama and K Isoyama Bone Marrow Transplant 2017 52: 1068-1070; advance online publication, April 3, 2017; 10.1038/bmt.2017.65 Full Text | | More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working PartyM Simonin, A Dalissier, M Labopin, A Willasch, M Zecca, A Mouhab, A Chybicka, A Balduzzi, L Volin, C Peters, P Bader and J-H Dalle on behalf of PDWP-EBMT Bone Marrow Transplant 2017 52: 1071-1073; advance online publication, April 10, 2017; 10.1038/bmt.2017.66 Full Text | | Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphomaJ El Cheikh, R Massoud, I Abudalle, B Haffar, R Mahfouz, M A Kharfan-Dabaja, T Jisr, A Mougharbel, A Ibrahim and A Bazarbachi Bone Marrow Transplant 2017 52: 1074-1077; advance online publication, April 10, 2017; 10.1038/bmt.2017.69 Full Text | | RBC depletion from a PBSC graftH Bonig and G Bug Bone Marrow Transplant 2017 52: 1078-1079; advance online publication, April 24, 2017; 10.1038/bmt.2017.72 Full Text | | Corrigenda | Top | | Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial resultsZ Liu, Y Zhang, H Xiao, Z Yao, H Zhang, Q Liu, B Wu, D Nie, Y Li, Y Pang, Z Fan, L Li, Z Jiang, F Duan, H Li, P Zhang, Y Gao, L Ouyang, C Yue, M Xie, C Shi, Y Xiao and S Wang Bone Marrow Transplant 2017 52: 1080; 10.1038/bmt.2017.85 Full Text | | | | Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, A van Biezen, L Volin, G Mufti, C Craddock, J Finke, C Richard, J Passweg, A Peniket, J Maertens, G Sucak, T Gedde-Dahl, A Vitek, A Nagler, D Blaise, D Beelen, N Maillard, R Schwerdtfeger, T de Witte and N Kroger Bone Marrow Transplant 2017 52: 1081; 10.1038/bmt.2017.86 Full Text | | | | Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmesP D E Miller, T I de Silva, R Skinner, M Gilleece, A Peniket, A Hamblin, D Greenfield, C Anthias, K Peggs, A Madrigal and J A Snowden on behalf of the BSBMT Clinical Trials Committee Bone Marrow Transplant 2017 52: 1082; 10.1038/bmt.2017.87 Full Text | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment